MTOR and cardiac hypertrophy: Mechanistic in vivo and in vitro studies demonstrated that miR-17-5p suppresses autophagy to promote cardiac hypertrophy by inhibiting Mfn2 expression, and activating the phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway.